Tianjin Pharmaceutical Da Ren Tang Group Proposes New Independent Director

SGX Filings
04/16

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that its board, at the third meeting for FY2026 held via teleconference on Apr, 16 2026, approved the proposal to appoint Ms. Zhai Shuping as an independent director for a three-year term.

Ms. Zhai, born in Sep, 1975, holds a Doctorate in Economics from Tianjin University of Finance and Economics and is currently a professor and doctoral supervisor at that university’s School of Accounting. She has previously served as an independent director at Tianjin Great Wall Binhai Automotive Finance Co., Ltd. and Jiangsu Gutian Automation Co., Ltd.

The appointment is subject to shareholders’ approval at the company’s upcoming annual general meeting for the financial year ended Dec, 31 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10